Assessment of DAFILON® Suture Material for Skin Closure

NCT ID: NCT04617041

Last Updated: 2023-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

115 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-11

Study Completion Date

2023-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this non-interventional study (NIS) a polyamide non-absorbable suture (Dafilon®) will be evaluated for skin closure in adult and pediatric patients. The aim of the study is to collect clinical data on the performance of Dafilon® for skin closure. The results of this study will generate further clinical evidence for the use and the benefit of a non-absorbable surgical suture material produced from polyamide. Furthermore, the proactive collection of clinical data for Dafilon® suture will support the maintenance of the suture material on the market, so that in the future other patients can receive the suture material for skin closure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laceration of Skin Injury Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent is available
* Patients undergoing skin closure with Dafilon®
* Small linear minimally contaminated incision/laceration in the trunk or extremities

Exclusion:

* Emergency surgery
* Pregnancy
* Facial lacerations or incisions
* Visible dirt in the wounds
* Nonlinear shape
* Patient taking medication that might affect wound healing
* Patient with hypersensitivity or allergy to the suture material
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aesculap AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manuel Guillermo López Paredes, Dr.

Role: PRINCIPAL_INVESTIGATOR

Hospital Vall D'Hebrón, Barcelona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Landkreis Tuttlingen, Dept. General Surgery

Tuttlingen, Baden-Wurttemberg, Germany

Site Status

Hospital Universitario Vall d'Hebron

Barcelona, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAG-O-H-1909

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hand Incision Study
NCT04656834 UNKNOWN